The fatty acid desaturase 2 (FADS2) gene product catalyzes ?4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells.

ABSTRACT: Docosahexaenoic acid (DHA) is a ?4-desaturated C22 fatty acid and the limiting highly unsaturated fatty acid (HUFA) in neural tissue. The biosynthesis of ?4-desaturated docosanoid fatty acids 22:6n-3 and 22:5n-6 are believed to proceed via a circuitous biochemical pathway requiring repeated use of a fatty acid desaturase 2 (FADS2) protein to perform ?6 desaturation on C24 fatty acids in the endoplasmic reticulum followed by 1 round of ?-oxidation in the peroxisomes. We demonstrate here that the FADS2 gene product can directly ?4-desaturate 22:5n-3?22:6n-3 (DHA) and 22:4n-6?22:5n-6. Human MCF-7 cells lacking functional FADS2-mediated ?6-desaturase were stably transformed with FADS2, FADS1, or empty vector. When incubated with 22:5n-3 or 22:4n-6, FADS2 stable cells produce 22:6n-3 or 22:5n-6, respectively. Similarly, FADS2 stable cells when incubated with d5-18:3n-3 show synthesis of d5-22:6n-3 with no labeling of 24:5n-3 or 24:6n-3 at 24 h. Further, both C24 fatty acids are shown to be products of the respective C22 fatty acids via elongation. Our results demonstrate that the FADS2 classical transcript mediates direct ?4 desaturation to yield 22:6n-3 and 22:5n-6 in human cells, as has been widely shown previously for desaturation by fish and many other organisms.

SUBMITTER: Park HG 

PROVIDER: S-EPMC4550368 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature